Biomarkers and the Clinical Benefit of Ezetimibe: A Prespecified Analysis from IMPROVE-IT
Arman Qamar, MD; Robert P. Giugliano, MD, SM; Erin A. Bohula, MD, DPhil; Jeong-Gun Park, PhD; Petr Jarolim, MD, PhD; Sabina A. Murphy, MPH; Christopher P. Cannon, MD; Eugene Braunwald, MD; David A. Morrow, MD, MPH. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA
Novel HDL markers may improve risk prediction for stroke: A meta-analysis of large population-based cohorts
Kavisha Singh MD1, Colby Ayers MS1, Anand Rohatgi MD, MSCS1. 1University of Texas Southwestern Medical Center, Dallas, TX, USA.